Horizon Discovery accelerates CRISPR gene editing workflows

By The Science Advisory Board staff writers

July 7, 2020 -- Horizon Discovery Group has introduced a new stably expressing Cas9 cell line for knockout experiments and a dCas9-VPR cell line for gene activation experiments.

The products are designed to work with Horizon's Edit-R predesigned synthetic single guide RNA and CRISPR guide RNA to create streamlined CRISPR gene editing and modulation workflows. The cell lines are generated using Edit-R lentiviral particles with a blasticidin resistance cassette.

Both lines are available in the same background to enable loss- and gain-of-function studies without the need to engineer specific cell lines. The time and money saved by removing this step will help researchers increase productivity and simplify CRISPR workflows.

The complete package of quality control-validated cell lines with Edit-R predesigned single guide RNA products and DharmaFect transfection reagents will be bundled for sale.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here